Eisai, Biogen get US FDA approval for Alzheimer's drug, apply for full approval - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

📆 2023-01-07 오후 10:39:00
📰 SABCNews

⏱ Reading Time:
45 sec. here
2 min. at publisher
📊 Quality Score:
News: 21%
Publisher: 51%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

The US Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in the earliest stages of the mind-wasting disease.

FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder/File PhotoFILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder/File Photo

Eisai said the drug would launch at an annual price of $26 500. Biogen shares, which had been halted, were up 3% at $279.40. “The new drug may not generate a significant profit immediately after the launch, but it will start contributing to our profit in the latter half of the second year or the third year,” he said without giving any concrete figure.

“Without Centers for Medicare & Medicaid Services and insurance coverage … access for those who could benefit from the newly-approved treatment will only be available to those who can pay out-of-pocket,” the Alzheimer’s Association said in a statement. If the drug receives traditional FDA approval, CMS said it would provide broader coverage. Eisai officials have said the company plans to submit data from a recent successful clinical trial in 1,800 patients as the basis for a full standard review of Leqembi.

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

댓글 쓰기

They must start giving this wonder to the old anc that keep forgetting what they promise

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

US FDA approves Eisai, Biogen Alzheimer's drug - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.The US Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd and Biogen Inc for patients in the earliest stages of the mind-wasting disease. I'm really grateful for all the efforts you have render to me with my little investment of R5000 and with joy over me after withdrawing R60,000 with your help Lisa_berry77 thank you for everything you have done for me and my family Lisa_berry77
출처: SABCNews - 🏆 37. / 51 더 많은 것을 읽으십시오 »